Guilin Sanjin Pharmaceutical Co., Ltd. (SHE: 002275)
China
· Delayed Price · Currency is CNY 13.41
-0.16 (-1.18%)
Sep 10, 2024, 3:04 PM CST
Guilin Sanjin Pharmaceutical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,049 | 2,168 | 1,954 | 1,739 | 1,564 | 1,639 | Upgrade
|
| Other Revenue | -3.1 | 3.66 | 5.27 | 2.71 | 2.79 | 1.6 | Upgrade
|
| Revenue | 2,046 | 2,172 | 1,960 | 1,741 | 1,566 | 1,640 | Upgrade
|
| Revenue Growth (YoY) | -5.22% | 10.81% | 12.55% | 11.15% | -4.51% | 3.52% | Upgrade
|
| Cost of Revenue | 553.38 | 602.57 | 574.37 | 457.04 | 449.25 | 445.36 | Upgrade
|
| Gross Profit | 1,492 | 1,569 | 1,385 | 1,284 | 1,117 | 1,195 | Upgrade
|
| Selling, General & Admin | 921.31 | 920.66 | 812.68 | 722.13 | 628.74 | 626.46 | Upgrade
|
| Research & Development | 173.48 | 158.06 | 217.04 | 201.6 | 147.56 | 99.65 | Upgrade
|
| Other Operating Expenses | 9.55 | 27.43 | 36.09 | 32.8 | 30.4 | 2.37 | Upgrade
|
| Operating Expenses | 1,099 | 1,106 | 1,070 | 957.81 | 803.92 | 729.58 | Upgrade
|
| Operating Income | 393.77 | 462.87 | 315.65 | 326.37 | 313.31 | 465.48 | Upgrade
|
| Interest Expense | -5.46 | -16.36 | -20.24 | -18.21 | -11.55 | -5.58 | Upgrade
|
| Interest & Investment Income | 20.77 | 33.17 | 40.64 | 39.8 | 29.41 | 31.85 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.08 | -0.08 | -3.59 | 0.57 | 0.01 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -8.49 | -0.34 | -0.58 | -1.23 | -0.14 | -0.6 | Upgrade
|
| EBT Excluding Unusual Items | 400.52 | 479.27 | 331.89 | 347.31 | 331.05 | 491.16 | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.34 | 1.19 | 0.16 | 1.77 | -1.37 | -23.24 | Upgrade
|
| Gain (Loss) on Sale of Assets | 8.44 | 1.67 | 31.26 | 15.5 | - | 1.1 | Upgrade
|
| Asset Writedown | -0.17 | -0.17 | -1.02 | -8.12 | -1.71 | -1.03 | Upgrade
|
| Other Unusual Items | 27.32 | 36.31 | 83.89 | 72.61 | 16.2 | -0.35 | Upgrade
|
| Pretax Income | 439.46 | 518.28 | 446.18 | 429.06 | 344.17 | 467.64 | Upgrade
|
| Income Tax Expense | 96.73 | 96.99 | 116.65 | 85.34 | 67.14 | 75.49 | Upgrade
|
| Net Income | 342.73 | 421.3 | 329.53 | 343.72 | 277.02 | 392.14 | Upgrade
|
| Net Income to Common | 342.73 | 421.3 | 329.53 | 343.72 | 277.02 | 392.14 | Upgrade
|
| Net Income Growth | -15.62% | 27.85% | -4.13% | 24.08% | -29.36% | -5.13% | Upgrade
|
| Shares Outstanding (Basic) | 588 | 585 | 588 | 573 | 577 | 585 | Upgrade
|
| Shares Outstanding (Diluted) | 588 | 585 | 588 | 573 | 577 | 585 | Upgrade
|
| Shares Change (YoY) | -1.07% | -0.56% | 2.72% | -0.74% | -1.39% | -0.88% | Upgrade
|
| EPS (Basic) | 0.58 | 0.72 | 0.56 | 0.60 | 0.48 | 0.67 | Upgrade
|
| EPS (Diluted) | 0.58 | 0.72 | 0.56 | 0.60 | 0.48 | 0.67 | Upgrade
|
| EPS Growth | -14.70% | 28.57% | -6.67% | 25.00% | -28.36% | -4.29% | Upgrade
|
| Free Cash Flow | 499.47 | 472.85 | 466.4 | 266.15 | 392.52 | 242.14 | Upgrade
|
| Free Cash Flow Per Share | 0.85 | 0.81 | 0.79 | 0.46 | 0.68 | 0.41 | Upgrade
|
| Dividend Per Share | 0.600 | 0.600 | 0.800 | 0.900 | 0.400 | 0.230 | Upgrade
|
| Dividend Growth | -25.00% | -25.00% | -11.11% | 125.00% | 73.91% | -34.29% | Upgrade
|
| Gross Margin | 72.95% | 72.25% | 70.69% | 73.75% | 71.32% | 72.85% | Upgrade
|
| Operating Margin | 19.25% | 21.31% | 16.11% | 18.74% | 20.00% | 28.38% | Upgrade
|
| Profit Margin | 16.75% | 19.40% | 16.81% | 19.74% | 17.68% | 23.90% | Upgrade
|
| Free Cash Flow Margin | 24.41% | 21.77% | 23.80% | 15.29% | 25.06% | 14.76% | Upgrade
|
| EBITDA | 486.12 | 556.38 | 412.21 | 412.97 | 393.58 | 556.17 | Upgrade
|
| EBITDA Margin | 23.76% | 25.62% | 21.03% | 23.72% | 25.12% | 33.90% | Upgrade
|
| D&A For EBITDA | 92.35 | 93.51 | 96.55 | 86.6 | 80.27 | 90.69 | Upgrade
|
| EBIT | 393.77 | 462.87 | 315.65 | 326.37 | 313.31 | 465.48 | Upgrade
|
| EBIT Margin | 19.25% | 21.31% | 16.11% | 18.74% | 20.00% | 28.38% | Upgrade
|
| Effective Tax Rate | 22.01% | 18.71% | 26.14% | 19.89% | 19.51% | 16.14% | Upgrade
|
| Revenue as Reported | 977.44 | 2,172 | 1,960 | 1,741 | 1,566 | 1,640 | Upgrade
|
| Advertising Expenses | - | 514.72 | 361.86 | 378.93 | 64.35 | 48.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.